These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28657913)

  • 1. Strong Correlation Between Concentrations of Antiretrovirals in Home-Collected and Study-Collected Hair Samples: Implications for Adherence Monitoring.
    Saberi P; Neilands TB; Ming K; Johnson MO; Kuncze K; Koss CA; Gandhi M
    J Acquir Immune Defic Syndr; 2017 Dec; 76(4):e101-e103. PubMed ID: 28657913
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiretroviral concentrations in small hair samples as a feasible marker of adherence in rural Kenya.
    Hickey MD; Salmen CR; Tessler RA; Omollo D; Bacchetti P; Magerenge R; Mattah B; Salmen MR; Zoughbie D; Fiorella KJ; Geng E; Njoroge B; Jin C; Huang Y; Bukusi EA; Cohen CR; Gandhi M
    J Acquir Immune Defic Syndr; 2014 Jul; 66(3):311-5. PubMed ID: 24694932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral drug concentrations in hair are associated with virologic outcomes among young people living with HIV in Tanzania.
    Tabb ZJ; Mmbaga BT; Gandhi M; Louie A; Kuncze K; Okochi H; Shayo AM; Turner EL; Cunningham CK; Dow DE
    AIDS; 2018 Jun; 32(9):1115-1123. PubMed ID: 29438196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan women.
    Koss CA; Natureeba P; Mwesigwa J; Cohan D; Nzarubara B; Bacchetti P; Horng H; Clark TD; Plenty A; Ruel TD; Achan J; Charlebois ED; Kamya MR; Havlir DV; Gandhi M
    AIDS; 2015 Apr; 29(7):825-30. PubMed ID: 25985404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nevirapine hair and plasma concentrations and HIV-1 viral suppression among HIV infected ante-partum and post-partum women attended in a mother and child prevention program in Maputo city, Mozambique.
    Cuco RM; Loquiha O; Juga A; Couto A; Meggi B; Vubil A; Sevene E; Osman N; Temermam M; Degomme O; Sidat M; Bhatt N
    PLoS One; 2022; 17(2):e0261522. PubMed ID: 35143515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of antiretroviral drugs in human hair with liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Wu Y; Yang J; Duan C; Chu L; Chen S; Qiao S; Li X; Deng H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1083():209-221. PubMed ID: 29550683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative Antiretroviral Exposure Measured in Hair Is Not Associated With Measures of HIV Persistence or Inflammation Among Individuals on Suppressive ART.
    Gandhi M; Gandhi RT; Stefanescu A; Bosch RJ; Cyktor JC; Horng H; Louie A; Phung N; Eron JJ; Hogg E; Macatangay BJC; Hensel C; Fletcher CV; Mellors JW; McMahon DK;
    J Infect Dis; 2018 Jun; 218(2):234-238. PubMed ID: 29529230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometry imaging of hair identifies daily maraviroc adherence in HPTN 069/ACTG A5305.
    Rosen EP; White N; Gilliland WM; Gerona RR; Gandhi M; Amico KR; Mayer KH; Gulick RM; Kashuba ADM
    PLoS One; 2023; 18(6):e0287449. PubMed ID: 37352285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moving Antiretroviral Adherence Assessments to the Modern Era: Correlations Among Three Novel Measures of Adherence.
    Saberi P; Chakravarty D; Ming K; Legnitto D; Gandhi M; Johnson MO; Neilands TB
    AIDS Behav; 2020 Jan; 24(1):284-290. PubMed ID: 31758349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of factors related to adherence to antiretroviral therapy among patients followed at HIV/AIDS Unit in the District Hospital of Dschang, Cameroon].
    Mbopi-Kéou FX; Dempouo Djomassi L; Monebenimp F
    Pan Afr Med J; 2012; 12():55. PubMed ID: 22937195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teleconsultation for the Pharmaceutical Care of HIV Outpatients in Receipt of Home Antiretrovirals Delivery: Clinical, Economic, and Patient-Perceived Quality Analysis.
    Margusino-Framiñán L; Cid-Silva P; Castro-Iglesias Á; Mena-de-Cea Á; Rodríguez-Osorio I; Pernas-Souto B; Vázquez-Rodríguez P; López-Calvo S; Martín-Herranz I
    Telemed J E Health; 2019 May; 25(5):399-406. PubMed ID: 30036159
    [No Abstract]   [Full Text] [Related]  

  • 12. The relationship between daily organization and adherence to antiretroviral therapy: a qualitative perspective.
    Saberi P; Comfort M; Johnson MO
    J Acquir Immune Defic Syndr; 2012 Sep; 61(1):e3-6. PubMed ID: 22918127
    [No Abstract]   [Full Text] [Related]  

  • 13. Mobile phone messaging to improve health.
    Kahol K
    BMJ; 2014 Oct; 349():g6158. PubMed ID: 25954987
    [No Abstract]   [Full Text] [Related]  

  • 14. Simplifying HIV cohort monitoring--pharmacy stock records minimize resources necessary to determine retention in care.
    Orrell C; Dipenaar R; Killa N; Tassie JM; Harries AD; Wood R
    J Acquir Immune Defic Syndr; 2013 Mar; 62(3):e106-8. PubMed ID: 23187944
    [No Abstract]   [Full Text] [Related]  

  • 15. Acceptability of obtaining hair samples for assessing antiretroviral therapy (ART) exposure amongst alcohol drinking ART recipients in Tshwane, South Africa.
    Kekwaletswe CT; Nkosi S; Kitleli NB; Myers B; Shuper P; Parry CDH; Morojele NK
    AIDS Care; 2018 Dec; 30(12):1498-1501. PubMed ID: 29779409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between social support and adherence to anti-retroviral treatment in people living with HIV.
    Oliveira RDS; Primeira MR; Santos WMD; Paula CC; Padoin SMM
    Rev Gaucha Enferm; 2020; 41():e20190290. PubMed ID: 32667420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Costs and adherence to antiretroviral treatment].
    Ventura-Cerdá JM; Ayago-Flores D; Vicente-Escrig E; Mollá-Cantavella S; Alós-Almiñana M
    Farm Hosp; 2010; 34(6):284-92. PubMed ID: 20692861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both improvement and worsening of adherence to antiretroviral treatment can be expected while transitioning HIV-positive adolescents to adult health care.
    Kowalska JD; Popielska J; Wroblewska A; Firląg-Burkacka E; Horban A; Marczyńska M
    Infect Dis (Lond); 2019 Jun; 51(6):463-466. PubMed ID: 30856034
    [No Abstract]   [Full Text] [Related]  

  • 19. Monthly unannounced pill counts for monitoring HIV treatment adherence: tests for self-monitoring and reactivity effects.
    Kalichman SC; Amaral C; Swetsze C; Eaton L; Kalichman MO; Cherry C; Detorio M; Caliendo AM; Schinazi RF
    HIV Clin Trials; 2010; 11(6):325-31. PubMed ID: 21239360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to antiretrovirals in people coinfected with the human immunodeficiency virus and tuberculosis.
    Lemos Lde A; Fiuza ML; Reis RK; Ferrer AC; Gir E; Galvão MT
    Rev Lat Am Enfermagem; 2016; 24():e2691. PubMed ID: 27192416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.